Ability Pharmaceuticals

company

About

Ability Pharmaceuticals is a drug discovery and development company.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
€5M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2009
Number Of Employee
1 - 10
Operating Status
Active

Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs.

Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures.

Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€5M
Ability Pharmaceuticals has raised a total of €5M in funding over 2 rounds. Their latest funding was raised on Mar 25, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 25, 2020 Grant €5M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Ability Pharmaceuticals is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Grant